Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela C Maxwell-Horn

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Sleep Medicine Reports|June 6, 2015
Sleep in Autism Spectrum DisordersOlivia J Veatch, Angela C Maxwell-Horn, Beth A Malow
Pharmacotherapy|December 16, 2022
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision supportMichelle Liu, Katelyn M Rossow, Angela C Maxwell-Horn, et al.
Pediatrics|November 25, 2020
Pharmacogenetics to Predict Adverse Events Associated With AntidepressantsKatelyn M Rossow, Ida T Aka, Angela C Maxwell-Horn, et al.
American Journal on Intellectual and Developmental Disabilities|August 24, 2021
Direct Measures of Medication Effects: Exploring the Scientific Utility of Behavior-Analytic AssessmentsBlair P Lloyd, Emily S Weaver, Jessica N Torelli, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|March 24, 2021
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in PediatricsKatelyn M Rossow, Kazeem A Oshikoya, Ida T Aka, et al.
Pediatric Research|January 21, 2019
CYP2D6 genotype and adverse events to risperidone in children and adolescentsKazeem A Oshikoya, Katelyn M Neely, Robert J Carroll, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Sleep Medicine Reports|June 6, 2015
Sleep in Autism Spectrum DisordersOlivia J Veatch, Angela C Maxwell-Horn, Beth A Malow
Pharmacotherapy|December 16, 2022
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision supportMichelle Liu, Katelyn M Rossow, Angela C Maxwell-Horn, et al.
Pediatrics|November 25, 2020
Pharmacogenetics to Predict Adverse Events Associated With AntidepressantsKatelyn M Rossow, Ida T Aka, Angela C Maxwell-Horn, et al.
American Journal on Intellectual and Developmental Disabilities|August 24, 2021
Direct Measures of Medication Effects: Exploring the Scientific Utility of Behavior-Analytic AssessmentsBlair P Lloyd, Emily S Weaver, Jessica N Torelli, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|March 24, 2021
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in PediatricsKatelyn M Rossow, Kazeem A Oshikoya, Ida T Aka, et al.
Pediatric Research|January 21, 2019
CYP2D6 genotype and adverse events to risperidone in children and adolescentsKazeem A Oshikoya, Katelyn M Neely, Robert J Carroll, et al.
Pageof 1